VI
Vista Pharmaceuticals Limited
VISTAPH.BO · BSE
₹5.75 +2.68% (+₹0.15)
1M -17.89%
Market Cap ₹361.3M
P/E Ratio -
Div. Yield -
ROE 27.48%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 9.31x
P/B 0.99x
P/E N/A
Growth
83 /100
Growing Rev. growth 75.22%
Book val. growth 0.24%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 25.65%
Net margin 302.95%
Op. margin 389.35%
Quality
1 /100
Poor ROIC 23.84%
ROE 27.48%
ROA 21.34%
Debt
54 /100
Moderate Debt/Equity 0.27x
Current ratio 0.92x
Int. coverage -11.99x
Stability
1 /100
Unstable Beta 0.10x
Rev. volatility 548.48%
EPS volatility 108.34%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VISTAPH.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Dhananjaya Alli
Employees
30
Headquarters
Hyderabad